Bank Of New York Mellon Corp Astrazeneca PLC Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$63.15 - $71.6 $53.7 Million - $60.9 Million	851,133 New	851,133 $59.1 Billion
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $46.1 Million - $59.8 Million	849,507 New	849,507 $57.6 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $1.16 Million - $2.98 Million	-21,971 Reduced 2.52%	849,142 $46.6 Million
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $1.29 Million - $1.55 Million	21,814 Added 2.57%	871,113 $57.6 Million
Q1 2022 May 11, 2022	BUY	$55.72 - $67.12 $17.9 Million - $21.6 Million	321,867 Added 61.03%	849,299 $56.3 Million
Q4 2021 Feb 11, 2022	SELL	$54.02 - $63.83 $18.3 Million - $21.6 Million	-338,738 Reduced 39.11%	527,432 $30.7 Million
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $37.4 Million - $40.9 Million	673,143 Added 348.73%	866,170 $52 Million
Q2 2021 Aug 11, 2021	BUY	$48.42 - $60.18 $158,381 - $196,848	3,271 Added 1.72%	193,027 $11.6 Million
Q1 2021 May 13, 2021	BUY	$47.16 - $54.44 $553,516 - $638,962	11,737 Added 6.59%	189,756 $9.43 Million
Q4 2020 Feb 09, 2021	SELL	$48.52 - $58.02 $1.16 Million - $1.39 Million	-23,908 Reduced 11.84%	178,019 $8.9 Million
Q3 2020 Nov 12, 2020	SELL	$53.07 - $61.1 $513,982 - $591,753	-9,685 Reduced 4.58%	201,927 $11.1 Million
Q2 2020 Aug 12, 2020	BUY	$43.1 - $55.31 $4.27 Million - $5.47 Million	98,975 Added 87.87%	211,612 $11.2 Million
Q1 2020 May 06, 2020	SELL	$37.79 - $51.33 $30,232 - $41,064	-800 Reduced 0.71%	112,637 $5.03 Million
Q4 2019 Feb 14, 2020	BUY	$42.46 - $50.46 $147,590 - $175,398	3,476 Added 3.16%	113,437 $5.66 Million
Q3 2019 Nov 07, 2019	SELL	$40.12 - $45.47 $199,757 - $226,395	-4,979 Reduced 4.33%	109,961 $4.9 Million
Q2 2019 Aug 12, 2019	SELL	$37.28 - $41.68 $1.34 Million - $1.5 Million	-36,037 Reduced 23.87%	114,940 $4.75 Million
Q1 2019 May 14, 2019	SELL	$35.49 - $43.02 $875,396 - $1.06 Million	-24,666 Reduced 14.04%	150,977 $6.1 Million
Q4 2018 Feb 11, 2019	SELL	$36.86 - $41.49 $467,863 - $526,632	-12,693 Reduced 6.74%	175,643 $6.67 Million
Q3 2018 Nov 09, 2018	BUY	$34.76 - $39.72 $367,065 - $419,443	10,560 Added 5.94%	188,336 $0
Q2 2018 Aug 06, 2018	SELL	$34.55 - $37.05 $325,668 - $349,233	-9,426 Reduced 5.04%	177,776 $6.24 Million
Q1 2018 May 15, 2018	SELL	$32.97 - $36.63 $1.11 Million - $1.23 Million	-33,681 Reduced 15.25%	187,202 $6.55 Million
Q4 2017 Feb 09, 2018	BUY	$32.09 - $34.78 $7.09 Million - $7.68 Million	220,883	220,883 $7.67 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.05 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.71 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.4 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.37 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.23 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account